维普中文期刊产品整合服务
196篇 您的检索式:作者名="HAFERLACH"
    题名 作者 年代 出处 被引量
1G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft显示文摘Dreger P Haferlach T Spanakis E 1994Haematol1994,87,4:2
2Compre- hensive genetic characterization of CLL:a study on 506 cases analysed with chromosome banding anaIysis, interphase FIS,I, IgV (H) stastus and immunophenotyping 显示文摘Haferlach DiekerF schnittger S 2007leukemia2007,21,12:1
3The quality of molec- ular response to chemotherapy is predictive for the outcome of AML1 - ETO - positive AML and is independent of pretreatment risk factors 显示文摘Weisser M Haferlach C Hiddemann W 2007Leukemia2007,21,6:1
4Diversity of the juxtamembrane and TKD1 mutations (Exons 13–15) in the FLT3 gene with regards to mutant load, sequence, length, localization, and correlation with biological data显示文摘Susanne Schnittger Ulrike Bacher Claudia Haferlach Tamara Alpermann Wolfgang Kern Torsten Haferlach 2012Genes Chromosom. Cancer2012,,:1
5A comparative study of molecular mutations in 381 patients with myelodysplastie syndrome and in 4130 patients with acute myeloid leukemia 显示文摘Ulrike Bacher Torsten Haferlach Wolfgang Kern 2007The hematology jouma2007,92,06:1
6Insight into THE mole cular pathogenesis of Myeloid malignancies显示文摘Haferlach T Bather U Haferlach C 2007Curt opin Hematol2007,14,:1
7AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes显示文摘Haferlach T Kohlmann A Schnittger S 2005Genes Chr Can2005,43,2:1
8KIT-D816 mutations in AML1/ETO-positive AML are associated with impaired event-free and overall survival 显示文摘Schnittger S Kohl TM Haferlach T 2006Blood2006,107,5:1
9Mutations of the TET2and CBL genes : novel molecular markers in myeloid malignancies显示文摘Bacher U Haferlach C Schnittger S 2010Ann Hematol2010,89,7:1
10Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT显示文摘Ditschkowski M Haferlach C Schulte C 0,,:1
11Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia : data from the German AML Cooperative Group(AMLCG)1992 Trial显示文摘Kern W Haferlach T Schoch C 2003Blood2003,101,:1
12Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate karyotype显示文摘SCHNITTQER S HAFERLACH T BACHER U 2012Leuk Res2012,36,1:1
13Molecular genetics of adult acute myeloid leukemia:prognostic and therapeutic implications显示文摘MARCUCCI G HAFERLACH T DOHNER H 2011Clin Oncol2011,29,5:1
14Modem diagnostics in acute Leukemia 显示文摘Haferlach T Kern W Schittger S 2005Critic Rev Oncol/Hematol2005,56,:1
15Insight into the molecular pathogenesis of myeloid malignancies显示文摘HAFERLACH T BACHER U HAFERLACH C 2007Curr Opin Hemato2007,14,2:1
16Monitoring of minimal residual disease in acute myeloid leukemia 显示文摘Kern W Schoch C Haferlach T 2005Crit Rev Oncol Hematol2005,56,12:1
17Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy : results of a multiparameter analysis from the german AML cooperative group studies显示文摘HAFERLACH T SCHOCH C LOFFLER H 2003J Clin Oncol2003,21,2:1
18Amount of bone marrow blasts is strongly correla?ted to NPM1 and FL T3- lTD mutation rate in AML with normal karyotype显示文摘HAFERLACH LBACHER U ALPERMANN L 2012Leuk Res2012,36,:1
19Monitoring of minimal residual disease in acute myeloid leukemia 显示文摘Kern W Haferlach C Haferlach T 2008Cancer2008,112,1:1
20A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia显示文摘BACHER U HAFERLACH T KERN W 2007Haematologica2007,92,:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费